Dr Echko Holman, in Saint Paul, MN - Medicare Internal Medicine

Dr Echko Holman, is a medicare enrolled "Internal Medicine" physician in Saint Paul, Minnesota. Her current practice location is 640 Jackson St, Saint Paul, Minnesota. You can reach out to her office (for appointments etc.) via phone at (512) 543-4566.

Dr Echko Holman is licensed to practice in Minnesota (license number 73226) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1033739651.

Contact Information

	Dr Echko Holman,
	640 Jackson St, Saint Paul, MN 55101-2502
	(512) 543-4566
	Not Available

Physician's Profile

Full Name	Dr Echko Holman
Gender	Female
Speciality	Internal Medicine
Location	640 Jackson St, Saint Paul, Minnesota
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1033739651
Provider Enumeration Date: 04/23/2020
Last Update Date: 09/01/2023

Medicare PECOS Information:

PECOS PAC ID: 4183042112
Enrollment ID: I20230921002293

Medical Identifiers

Medical identifiers for Dr Echko Holman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033739651	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	73226 (Minnesota)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Echko Holman allows following entities to bill medicare on her behalf.

Entity Name	Group Health Plan Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417

News Archive

Gene found that regulates blood-forming fetal stem cells

In the rancorous public debate over federal research funding, stem cells are generally assigned to one of two categories: embryonic or adult.

Children with food allergies experience bullying: Study

In the first ever study to assess the social impact of food allergies in children, Mount Sinai researchers have found that approximately 35 percent of children with food allergies, who are over the age of five, were reported to have experienced bullying, teasing, or harassment as a result of their allergies.

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that it conducted its first clinical Investigators Meeting for Oregovomab in Rome, Italy.

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D, the company's controlled-release latanoprost insert for the treatment of glaucoma.

Entity Name	Hutchinson Health
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1053508820 PECOS PAC ID: 0345330072 Enrollment ID: O20080312000695

Gene found that regulates blood-forming fetal stem cells

In the rancorous public debate over federal research funding, stem cells are generally assigned to one of two categories: embryonic or adult.

Children with food allergies experience bullying: Study

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Entity Name	Healthpartners Rc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1649470782 PECOS PAC ID: 5890126726 Enrollment ID: O20200618000378

Gene found that regulates blood-forming fetal stem cells

In the rancorous public debate over federal research funding, stem cells are generally assigned to one of two categories: embryonic or adult.

Children with food allergies experience bullying: Study

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Echko Holman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Echko Holman, 8170 33rd Ave S # Ms 21110q, Bloomington, MN 55425-4516 Ph: () -	Dr Echko Holman, 640 Jackson St, Saint Paul, MN 55101-2502 Ph: (512) 543-4566

News Archive

Gene found that regulates blood-forming fetal stem cells

In the rancorous public debate over federal research funding, stem cells are generally assigned to one of two categories: embryonic or adult.

Children with food allergies experience bullying: Study

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Internal Medicine Doctors in Saint Paul, MN

Wojciech Kraszkiewicz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-3456 Fax: 651-254-9673
Nicholas Charles Boysen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-3456 Fax: 651-254-9673
Nathan M Frink, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1690 University Ave W, Suite 570, Saint Paul, MN 55104 Phone: 651-232-4800 Fax: 651-232-4899
Dr. Andrew Caraganis, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Phalen Blvd, Saint Paul, MN 55130 Phone: 651-254-7670 Fax: 651-254-7676
Dr. Patrick George Manning, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-4887 Fax: 651-254-1603
Anthony Williams, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-3456 Fax: 651-254-9673
Samantha May Scheid, Internal Medicine Medicare: Medicare Enrolled Practice Location: 401 Phalen Blvd, Saint Paul, MN 55130 Phone: 651-254-7980

Dr Echko Holman, - Medicare Internal Medicine in Saint Paul, MN

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Gene found that regulates blood-forming fetal stem cells

Children with food allergies experience bullying: Study

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Gene found that regulates blood-forming fetal stem cells

Children with food allergies experience bullying: Study

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Gene found that regulates blood-forming fetal stem cells

Children with food allergies experience bullying: Study

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Gene found that regulates blood-forming fetal stem cells

Children with food allergies experience bullying: Study

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Internal Medicine Doctors in Saint Paul, MN